| P50 | author | Matthias G von Herrath | Q88828481 |
| | Stephen Schoenberger | Q58385799 |
| P2093 | author name string | Dirk Homann | |
| | Anna Hughes | |
| | Marianne J B van Stipdonk | |
| | Angelika Jahreis | |
| | Bryan Coon | |
| | Tom Wolfe | |
| | Kiley R Prilliman | |
| P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
| | Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen | Q28141785 |
| | B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 |
| | Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset | Q28290931 |
| | The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells | Q30468363 |
| | Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens | Q30990189 |
| | Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis | Q33835268 |
| | Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses | Q33971036 |
| | Interferons alpha and beta as immune regulators--a new look | Q34289965 |
| | Type 1 diabetes: new perspectives on disease pathogenesis and treatment | Q34321603 |
| | Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse | Q36364541 |
| | Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets | Q73785333 |
| | Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells | Q73838320 |
| | A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis | Q73966607 |
| | Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR | Q74286685 |
| | Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand | Q74532600 |
| | Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo | Q77323598 |
| | Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates | Q77890140 |
| | A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis | Q36366458 |
| | Models of T cell anergy: is there a common molecular mechanism? | Q36366967 |
| | Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified | Q36367631 |
| | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression | Q36368539 |
| | Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) | Q36375450 |
| | Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus | Q36376535 |
| | Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism | Q36380421 |
| | Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. | Q36417432 |
| | CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis | Q37696199 |
| | Dendritic cells acquire antigens from live cells for cross-presentation to CTL. | Q40822225 |
| | Induction of immunologic tolerance for transplantation | Q40827011 |
| | A subset of cytolytic dendritic cells in rat. | Q40848495 |
| | The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity | Q41654453 |
| | Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. | Q41700461 |
| | Functional expression of B7/BB1 on activated T lymphocytes | Q41898118 |
| | CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. | Q41898717 |
| | Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system | Q41932073 |
| | B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy | Q42675165 |
| | Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function | Q42767949 |
| | Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. | Q43612872 |
| | Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response | Q43986613 |
| | Regulation of adaptive immunity by natural killer cells | Q45112156 |
| | Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. | Q45739717 |
| | Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes. | Q45739869 |
| | NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells | Q45744756 |
| | How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model | Q45783598 |
| | Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice | Q45854348 |
| | Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. | Q45969254 |
| | Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory | Q46347403 |
| | Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes | Q46495737 |
| | Treatment of murine lupus with CTLA4Ig | Q46538983 |
| | T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions | Q47982736 |
| | Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 |
| | A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 |
| | The development, maturation, and turnover rate of mouse spleen dendritic cell populations. | Q52143353 |
| | CD8+ T Cells Rapidly Acquire NK1.1 and NK Cell-Associated Molecules Upon Stimulation In Vitro and In Vivo | Q56953519 |
| | Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells | Q58235001 |
| | Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance | Q61651670 |
| | Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes | Q71068093 |
| | Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches | Q71420915 |
| | Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 | Q72093299 |
| | Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat | Q73033716 |
| | Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction | Q73347843 |
| | Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells | Q73505005 |
| | Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation | Q73679954 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 403-415 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells | |
| P478 | volume | 16 | |